Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1303 | 2020 |
Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 461 | 2020 |
Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 176 | 2020 |
Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 156 | 2020 |
The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19 J Cai, H Li, C Zhang, Z Chen, H Liu, F Lei, JJ Qin, YM Liu, F Zhou, X Song, ... Cell metabolism 33 (2), 258-269. e3, 2021 | 113 | 2021 |
Kidney function indicators predict adverse outcomes of COVID-19 YM Liu, J Xie, MM Chen, X Zhang, X Cheng, H Li, F Zhou, JJ Qin, F Lei, ... Med 2 (1), 38-48. e2, 2021 | 77 | 2021 |
Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality F Zhou, YM Liu, J Xie, H Li, F Lei, H Yang, JJ Qin, J Cai, XJ Zhang, B Wu, ... Hypertension 76 (2), e15-e17, 2020 | 72 | 2020 |
Functional analysis of OsPGIP1 in rice sheath blight resistance R Wang, L Lu, X Pan, Z Hu, F Ling, Y Yan, Y Liu, Y Lin Plant molecular biology 87, 181-191, 2015 | 65 | 2015 |
A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease C Yang, Q He, Z Chen, JJ Qin, F Lei, YM Liu, W Liu, MM Chen, T Sun, ... Frontiers in Endocrinology 13, 821689, 2022 | 19 | 2022 |
Activating or inhibiting Nrf2? XY Chu, YM Liu, HY Zhang Trends in Pharmacological Sciences 38 (11), 953-955, 2017 | 19 | 2017 |
Phosphates as energy sources to expand metabolic networks T Tian, XY Chu, Y Yang, X Zhang, YM Liu, J Gao, BG Ma, HY Zhang Life 9 (2), 43, 2019 | 18 | 2019 |
Facilitating anti-cancer combinatorial drug discovery by targeting epistatic disease genes Y Quan, MY Liu, YM Liu, LD Zhu, YS Wu, ZH Luo, XZ Zhang, SZ Xu, ... Molecules 23 (4), 736, 2018 | 15 | 2018 |
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients Z Chen, J Chen, J Zhou, F Lei, F Zhou, JJ Qin, XJ Zhang, L Zhu, YM Liu, ... Current Medical Research and Opinion 37 (6), 917-927, 2021 | 13 | 2021 |
Systems chemical genetics-based drug discovery: prioritizing agents targeting multiple/reliable disease-associated genes as drug candidates Y Quan, ZH Luo, QY Yang, J Li, Q Zhu, YM Liu, BM Lv, ZJ Cui, X Qin, ... Frontiers in Genetics 10, 474, 2019 | 13 | 2019 |
Systems genetic validation of the SNP-metabolite association in rice via metabolite-pathway-based phenome-wide association scans Y Lu, Y Liu, X Niu, Q Yang, X Hu, HY Zhang, J Xia Frontiers in plant science 6, 1027, 2015 | 9 | 2015 |
HPO-Shuffle: an associated gene prioritization strategy and its application in drug repurposing for the treatment of canine epilepsy S Wang, X Meng, Y Wang, Y Liu, J Xia Bioscience Reports 39 (9), BSR20191247, 2019 | 8 | 2019 |
Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery ZJ Cui, YM Liu, Q Zhu, J Xia, HY Zhang Oncotarget 9 (17), 13181, 2018 | 3 | 2018 |
A corpus-oriented perspective on terminologies of side effect and adverse reaction in support of text retrieval for drug repurposing AC Fang, Y Liu, Y Lu, J Cao, J Xia International Journal of Data Mining and Bioinformatics 21 (3), 269-286, 2018 | 3 | 2018 |
Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway YM Liu, AD Wu, Y Chen, TF Ma, BZ Dong, ZG She, ML Yi, WM Mao Medical Oncology 41 (1), 1-10, 2024 | | 2024 |
The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroids therapy in patients with COVID-19 (preprint) J Cai, H Li, YM Liu, C Zhang, F Lei, JJ Qin, F Zhou, X Song, L Bai, J Zhou, ... | | 2020 |